|
Market Closed -
Nasdaq
16:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 1.350 USD | -2.17% |
|
+3.45% | +8.00% |
| 10-05 | Pmv Pharmaceuticals, Inc. Announces Appointment of Matt Eckler to Its Board of Directors | CI |
| 09-08 | PMV Pharmaceuticals, Inc. Announces Appointment of Philip Herman as Chief Commercial Officer | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PMVP | Delayed | |
CBOE
| PMVP | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1.39 | 1.79 | 1.79 |
| Spread/Res. | -2.88% | -24.58% | -24.58% |
| Spread/Supp. | +19.47% | +28.57% | +29.81% |
| Support | 1.13 | 1.05 | 1.04 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PMVP Stock
- Charts PMV Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
